Spatial proteomics identifies JAKi as treatment for a lethal skin disease
Nature · 28.11.2024 · 635 (8040) · 1001-1009
DOI: 10.1038/s41586-024-08061-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 16.10.2024. Verfasst von Thierry M Nordmann und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Proteomics and Signal Transduction; Max Planck Institute of Biochemistry, Martinsried, Germany. nordmann@biochem.mpg.de. Hauptthemen laut MEDLINE: Janus Kinase 1, Janus Kinase Inhibitors, Keratinocytes, Proteomics. Die Arbeit wurde bisher 161-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Toxic epidermal necrolysis (TEN) is a fatal drug-induced skin reaction triggered by common medications and is an emerging public health issue 1–3 . Patients with TEN undergo severe and sudden epidermal detachment caused by keratinocyte cell death. Although molecular mechanisms that drive keratinocyte cell death have been proposed, the main drivers remain unknown, and there is no effective therapy for TEN 4–6 . Here, to systematically map molecular changes that are associated with TEN and identify potential druggable targets, we utilized deep visual proteomics, which provides single-cell-based, cell-type-resolution proteomics 7,8 . We analysed formalin-fixed, paraffin-embedded archived skin tissue biopsies of three types of cutaneous drug reactions with varying severity and quantified more than 5,000 proteins in keratinocytes and skin-infiltrating immune cells. This revealed a marked enrichment of type I and type II interferon signatures in the immune cell and keratinocyte compartment of patients with TEN, as well as phosphorylated STAT1 activation. Targeted inhibition with the pan-JAK inhibitor tofacitinib in vitro reduced keratinocyte-directed cytotoxicity. In vivo oral administration of tofacitinib, baricitinib or the JAK1-specific inhibitors abrocitinib or upadacitinib ameliorated clinical and histological disease severity in two distinct mouse models of TEN. Crucially, treatment with JAK inhibitors (JAKi) was safe and associated with rapid cutaneous re-epithelialization and recovery in seven patients with TEN. This study uncovers the JAK/STAT and interferon signalling pathways as key pathogenic drivers of TEN and demonstrates the potential of targeted JAKi as a curative therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Proteomics and Signal Transduction; Max Planck Institute of Biochemistry, Martinsried, Germany. nordmann@biochem.mpg.de.
- Department of Dermatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. nordmann@biochem.mpg.de.
- Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany. nordmann@biochem.mpg.de.
- Inflammation division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
- Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
- Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
ORCID-Profile: Thierry M Nordmann, Holly Anderton, Andreas Metousis, Florian A Rosenberger, Maximilian Zwiebel, Takashi K Satoh, Marvin Thielert, Haruna Kimura, Gaetana Restivo, Laurence Feldmeyer, Mitchell P Levesque, Peter J Murray, Andreas Mund, John Silke, Chao Ji, Lars E French, Matthias Mann
Zitieren
APA
Nordmann, T. M., Anderton, H., Hasegawa, A., Schweizer, L., Zhang, P., Stadler, P. C., Sinha, A., Metousis, A., Rosenberger, F. A., Zwiebel, M., Satoh, T. K., Anzengruber, F., Strauss, M. T., Tanzer, M. C., Saito, Y., Gong, T., Thielert, M., Kimura, H., Silke, N., …, & Mann, M. (2024). Spatial proteomics identifies JAKi as treatment for a lethal skin disease. Nature, 635(8040), 1001-1009. https://doi.org/10.1038/s41586-024-08061-0
Vancouver
Nordmann TM, Anderton H, Hasegawa A, Schweizer L, Zhang P, Stadler PC, et al. Spatial proteomics identifies JAKi as treatment for a lethal skin disease. Nature. 2024;635(8040):1001-1009. doi:10.1038/s41586-024-08061-0
BibTeX
@article{Nordmann2024,
author = {Nordmann, Thierry M and Anderton, Holly and Hasegawa, Akito and Schweizer, Lisa and Zhang, Peng and Stadler, Pia-Charlotte and Sinha, Ankit and Metousis, Andreas and Rosenberger, Florian A and Zwiebel, Maximilian and Satoh, Takashi K and Anzengruber, Florian and Strauss, Maximilian T and Tanzer, Maria C and Saito, Yuki and Gong, Ting and Thielert, Marvin and Kimura, Haruna and Silke, Natasha and Rodriguez, Edwin H and Restivo, Gaetana and Nguyen, Hong Ha and Gross, Annette and Feldmeyer, Laurence and Joerg, Lukas and Levesque, Mitchell P and Murray, Peter J and Ingen-Housz-Oro, Saskia and Mund, Andreas and Abe, Riichiro and Silke, John and Ji, Chao and French, Lars E and Mann, Matthias},
title = {Spatial proteomics identifies JAKi as treatment for a lethal skin disease},
journal = {Nature},
year = {2024},
volume = {635},
number = {8040},
pages = {1001--1009},
doi = {10.1038/s41586-024-08061-0}
}
EUVIMED